Logo
x

Search category

Subscribe Now

Multiple Cancer Indications

Shreis Scalene's Cytotron Receives the US FDA's Breakthrough Device Designation for the Treatment of Multiple Cancer Indications

Shreis Scalene's Cytotron Receives the US FDA's Breakthrough Device Designation for the Treatment of Multiple Cancer Indications

  • October 31, 2019
MSD Collaborates with I-Mab to Evaluate Keytruda + TJC4 for Multiple Cancer Indications

MSD Collaborates with I-Mab to Evaluate Keytruda + TJC4 for Multiple Cancer Indications

  • September 24, 2019
Teva Canada's Herzuma (biosimilar- trastuzumab) Receives Health Canada Approval for Multiple Cancer Indications

Teva Canada's Herzuma (biosimilar- trastuzumab) Receives Health Canada Approval for Multiple Cancer Indications

  • September 12, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.